(Reuters) – Illumina said on Friday it would divest cancer test maker Grail in 12 months, according to the terms of the order by the European Commission, if it does not win its challenge in court.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar)
